155 related articles for article (PubMed ID: 34315041)
21. Synthesis and structure-activity relationships of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives as 5-lipoxygenase inhibitors.
Phillips OA; Bosso MA; Ezeamuzie CI
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1471-1482. PubMed ID: 32635785
[TBL] [Abstract][Full Text] [Related]
22. Biological Evaluation and Molecular Docking Studies of Novel 1,3,4-Oxadiazole Derivatives of 4,6-Dimethyl-2-sulfanylpyridine-3-carboxamide.
Świątek P; Glomb T; Dobosz A; Gębarowski T; Wojtkowiak K; Jezierska A; Panek JJ; Świątek M; Strzelecka M
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008977
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and anti-inflammatory activity of some novel 1,3,4-oxadiazole derivatives.
Abd el-Samii ZK
J Chem Technol Biotechnol; 1992; 53(2):143-6. PubMed ID: 1368010
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of novel myrtucommulones and structural analogues that target mPGES-1 and 5-lipoxygenase.
Wiechmann K; Müller H; Huch V; Hartmann D; Werz O; Jauch J
Eur J Med Chem; 2015 Aug; 101():133-49. PubMed ID: 26123643
[TBL] [Abstract][Full Text] [Related]
25. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity.
Bansal S; Bala M; Suthar SK; Choudhary S; Bhattacharya S; Bhardwaj V; Singla S; Joseph A
Eur J Med Chem; 2014 Jun; 80():167-74. PubMed ID: 24780593
[TBL] [Abstract][Full Text] [Related]
27. Convenient synthesis and biological profile of 5-amino-substituted 1,2,4-oxadiazole derivatives.
Ispikoudi M; Amvrazis M; Kontogiorgis C; Koumbis AE; Litinas KE; Hadjipavlou-Litina D; Fylaktakidou KC
Eur J Med Chem; 2010 Dec; 45(12):5635-45. PubMed ID: 20888086
[TBL] [Abstract][Full Text] [Related]
28. Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network.
He C; Wu Y; Lai Y; Cai Z; Liu Y; Lai L
Mol Biosyst; 2012 Apr; 8(5):1585-94. PubMed ID: 22446875
[TBL] [Abstract][Full Text] [Related]
29. New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability.
Abd-Ellah HS; Abdel-Aziz M; Shoman ME; Beshr EAM; Kaoud T; Ahmed AFF
Bioorg Chem; 2017 Oct; 74():15-29. PubMed ID: 28738249
[TBL] [Abstract][Full Text] [Related]
30. Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening.
Cerchia C; Küfner L; Werz O; Lavecchia A
Eur J Med Chem; 2024 Jan; 263():115932. PubMed ID: 37976708
[TBL] [Abstract][Full Text] [Related]
31. The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP).
Pergola C; Gerstmeier J; Mönch B; Çalışkan B; Luderer S; Weinigel C; Barz D; Maczewsky J; Pace S; Rossi A; Sautebin L; Banoglu E; Werz O
Br J Pharmacol; 2014 Jun; 171(12):3051-64. PubMed ID: 24641614
[TBL] [Abstract][Full Text] [Related]
32. Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and in silico studies.
Bashir B; Shahid W; Ashraf M; Saleem M; Aziz-Ur-Rehman ; Muzaffar S; Imran M; Amjad H; Bhattarai K; Riaz N
Bioorg Chem; 2021 Oct; 115():105243. PubMed ID: 34403937
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and molecular docking of novel 3,5-disubstituted-1,3,4-oxadiazole derivatives as iNOS inhibitors.
Koksal M; Dedeoglu-Erdogan A; Bader M; Gurdal EE; Sippl W; Reis R; Ozgurbuz M; Sipahi H; Celik T
Arch Pharm (Weinheim); 2021 Aug; 354(8):e2000469. PubMed ID: 33969533
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Dual 5-Lipoxygenase/Microsomal Prostaglandin E2 Synthase-1 Inhibitory Effect of Natural and Synthetic Acronychia-Type Isoprenylated Acetophenones.
Svouraki A; Garscha U; Kouloura E; Pace S; Pergola C; Krauth V; Rossi A; Sautebin L; Halabalaki M; Werz O; Gaboriaud-Kolar N; Skaltsounis AL
J Nat Prod; 2017 Mar; 80(3):699-706. PubMed ID: 28240894
[TBL] [Abstract][Full Text] [Related]
35. Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade.
Sala A; Proschak E; Steinhilber D; Rovati GE
Biochem Pharmacol; 2018 Dec; 158():161-173. PubMed ID: 30315753
[TBL] [Abstract][Full Text] [Related]
36. Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, in-vivo, in-vitro and in-silico analysis.
Kumar D; Kumar RR; Pathania S; Singh PK; Kalra S; Kumar B
Bioorg Chem; 2021 Sep; 114():105068. PubMed ID: 34130110
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
Koeberle A; Werz O
Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel of 2, 5-disubstituted 1, 3, 4- oxadiazole derivatives and their in vitro anti-inflammatory, anti-oxidant evaluation, and molecular docking study.
Kashid BB; Salunkhe PH; Dongare BB; More KR; Khedkar VM; Ghanwat AA
Bioorg Med Chem Lett; 2020 Jun; 30(12):127136. PubMed ID: 32280025
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX.
Huang Y; Zhang B; Li J; Liu H; Zhang Y; Yang Z; Liu W
Eur J Med Chem; 2019 Oct; 180():41-50. PubMed ID: 31299586
[TBL] [Abstract][Full Text] [Related]
40. Regulation of eicosanoid biosynthesis in the macrophage. Involvement of protein tyrosine phosphorylation and modulation by selective protein tyrosine kinase inhibitors.
Glaser KB; Sung A; Bauer J; Weichman BM
Biochem Pharmacol; 1993 Feb; 45(3):711-21. PubMed ID: 8442770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
